Effect of LIK066 on Body Weight in Patients With Elevated Body Mass Index
Completed · Phase 2 · Has a placebo group
Conditions studied: Elevated Body Mass Index
In brief
A 12-week study to assess LIK066 effect on body weight in diabetics, prediabetics and normoglycemic patients with elevated body mass index (BMI)
Key facts
- Study ID
- NCT02470403
- Run by
- Novartis Pharmaceuticals
- People needed
- 181
- Starts
- 2015-06-05
- Expected to finish
- 2016-04-04
- Last updated by the study team
- 2021-01-05
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novartis Investigative Site — Lincoln, Nebraska, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.